Skip to main content

Chest-Compression-Only CPR Shows Long-Term Survival Benefit


PARIS, France — The short-term mortality benefit of using chest compressions only rather than chest compressions plus rescue breathing in the resuscitation of patients with out-of-hospital cardiac arrest appears to be continued in the long term, a new study suggests [1].
The study, published online in Circulation on December 10, 2012, was conducted by a team led by Dr Florence Dumas(Descartes University, Paris, France).
They conclude: "The current results provide important evidence that chest-compression alone . . . can achieve better overall prognosis and should be considered the . . . approach for nearly all adult patients for whom dispatchers suspect cardiac arrest."
The researchers combined data from two randomized trials comparing chest compression alone or chest compression plus rescue breathing on short-term mortality and ascertained long-term vital status of patients from national and state death records.
Results showed that among the 2496 subjects there were 2260 deaths and 236 long-term survivors. Randomization to chest compression alone compared with chest compression plus rescue breathing was associated with a lower risk of death in the long term (one, three, and five years) after adjustment for potential confounders (adjusted HR=0.91; 95% CI 0.83–0.99).
"Meaningful Long-Term Public-Health Benefits"
The authors say that they had expected that the early survival difference may have been amplified after hospital discharge, but this was not seen. Rather, the long-term survival benefit of the chest-compressions-alone approach appeared to be attributable entirely to an early survival differential that persisted over subsequent years of follow-up, with the survival curves during long-term follow-up running parallel. But these results still suggest that short-term-outcome differences do translate to meaningful long-term public-health benefits, they add.
It has previously been suggested that chest compressions alone would be beneficial only for patients with collapse of cardiac origin and those with a shockable rhythm. Subgroup analysis of the current data, while not statistically definitive, supports this view, but there was no evidence of harm among those for whom oxygenation and ventilation might in theory be more important such as noncardiac etiology or unwitnessed arrest, the paper notes.
The authors add: "The results are specific to dispatcher-assisted layperson CPR, though they provide a useful context to consider layperson CPR training and guidelines."
Noting that laypersons are often especially challenged to perform effective rescue breathing even after training, they conclude that the current results "support the 2010 guidelines that prioritize chest compressions regardless of training status or dispatcher assistance."

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more